TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
SinoMab Bioscience Ltd. ( (HK:3681) ) just unveiled an announcement.
SinoMab BioScience Limited has announced the postponement and change of venue for its 2025 Annual General Meeting (AGM) due to administrative reasons. Originally scheduled for June 13, 2025, the AGM will now take place on June 30, 2025, at a new location in Hong Kong. Additionally, the book closure period for determining shareholders’ entitlement to attend and vote at the AGM has been adjusted. The withdrawal of an ordinary resolution concerning the re-election of an independent director, due to his passing, was also noted. These changes are expected to impact the company’s operational schedule and shareholder engagement.
More about SinoMab Bioscience Ltd.
SinoMab BioScience Limited is a company incorporated in Hong Kong, operating in the biotechnology industry. The company focuses on the development of therapeutic products, particularly in the field of immunology, aiming to address unmet medical needs.
Average Trading Volume: 4,923,303
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.01B
For a thorough assessment of 3681 stock, go to TipRanks’ Stock Analysis page.